This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitât Bern. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations in Insulin Delivery: The Contributions of Peter Diem
Introduction
Peter Diem is an innovative inventor based in Bern, Switzerland. He has made significant contributions to the field of diabetes management through his research and development of advanced insulin delivery systems. His work focuses on utilizing reinforcement learning algorithms to optimize insulin administration for patients with diabetes.
Latest Patents
Peter Diem holds a patent for the "Estimation of insulin based on reinforcement learning." This patent describes a method for determining the optimal insulin to be delivered by an insulin infusion pump. The algorithm aims to personalize glucose regulation by optimizing the daily basal insulin rate and insulin-to-carbohydrate ratio based on each patient's measured glucose profile. The proposed algorithm is capable of learning in real-time from patient-specific characteristics captured in the daily glucose profile, thereby providing individualized insulin treatment. An automatic and personalized tuning method enhances the performance of the algorithm.
Career Highlights
Peter Diem is affiliated with the University of Bern, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to improve the quality of life for individuals managing diabetes. With a focus on personalized medicine, Diem's contributions are paving the way for more effective treatment options.
Collaborations
Peter Diem has worked alongside notable colleagues such as Stavroula Mougiakakou and Eleni Daskalaki. Their collaborative efforts have further advanced the research in insulin delivery systems and personalized diabetes management.
Conclusion
Peter Diem's innovative approach to insulin delivery through reinforcement learning algorithms represents a significant advancement in diabetes care. His patent and ongoing research at the University of Bern highlight the importance of personalized treatment in managing chronic conditions. The impact of his work is expected to benefit many patients in the future.